Literature DB >> 11558789

Central and peripheral nervous system infection, immunity, and inflammation in the NHP model of Lyme borreliosis.

A R Pachner1, D Cadavid, G Shu, D Dail, S Pachner, E Hodzic, S W Barthold.   

Abstract

The relationship between chronic infection, antispirochetal immunity, and inflammation is unknown in Lyme neuroborreliosis. In the nonhuman primate model of Lyme neuroborreliosis, we measured spirochetal density in the nervous system and other tissues by polymerase chain reaction and correlated these values to anti-Borrelia burgdorferi antibody in the serum and cerebrospinal fluid, and to inflammation in tissues. Despite substantial presence of Borrelia burgdorferi, the causative agent of Lyme borreliosis, in the central nervous system, only minor inflammation was present there, though skeletal and cardiac muscle, which contained similar levels of spirochete, were highly inflamed. Anti-Borrelia burgdoferi antibody was present in the cerebrospinal fluid but was not selectively concentrated. All infected animals developed anti-Borrelia burgdorferi antibody in the serum, but increased amplitude of antibody was not predictive of higher levels of infection. These data demonstrate that Lyme neuroborreliosis is a persistent infection, that spirochetal presence is a necessary but not sufficient condition for inflammation, and that antibody measured in serum may not predict the severity of infection.

Entities:  

Mesh:

Year:  2001        PMID: 11558789

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  14 in total

1.  Interleukin 10 protects the brain microcirculation from spirochetal injury.

Authors:  Diana Londoño; Jenny Carvajal; Carolina Arguelles-Grande; Adriana Marques; Diego Cadavid
Journal:  J Neuropathol Exp Neurol       Date:  2008-10       Impact factor: 3.685

2.  Humoral immune response associated with lyme borreliosis in nonhuman primates: analysis by immunoblotting and enzyme-linked immunosorbent assay with sonicates or recombinant proteins.

Authors:  A R Pachner; D Dail; L Li; L Gurey; S Feng; E Hodzic; S Barthold
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

Review 3.  The mammalian host response to borrelia infection.

Authors:  Diego Cadavid
Journal:  Wien Klin Wochenschr       Date:  2006-11       Impact factor: 1.704

Review 4.  The role of infections in autoimmune disease.

Authors:  A M Ercolini; S D Miller
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

5.  Global transcriptome analysis of Borrelia burgdorferi during association with human neuroglial cells.

Authors:  Jill A Livengood; Virginia L Schmit; Robert D Gilmore
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

6.  Toll-like receptors: insights into their possible role in the pathogenesis of lyme neuroborreliosis.

Authors:  Andrea L F Bernardino; Tereance A Myers; Xavier Alvarez; Atsuhiko Hasegawa; Mario T Philipp
Journal:  Infect Immun       Date:  2008-08-11       Impact factor: 3.441

7.  Borrelia burgdorferi transcriptome in the central nervous system of non-human primates.

Authors:  Sukanya Narasimhan; Melissa J Caimano; Fang Ting Liang; Felix Santiago; Michelle Laskowski; Mario T Philipp; Andrew R Pachner; Justin D Radolf; Erol Fikrig; Melissa J Camaino
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-11       Impact factor: 11.205

Review 8.  Lyme disease.

Authors:  Patricia K Coyle
Journal:  Curr Neurol Neurosci Rep       Date:  2002-11       Impact factor: 5.081

9.  Lyme disease and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS): an overview.

Authors:  Hanna Rhee; Daniel J Cameron
Journal:  Int J Gen Med       Date:  2012-02-22

10.  Infection and inflammation in skeletal muscle from nonhuman primates infected with different genospecies of the Lyme disease spirochete Borrelia burgdorferi.

Authors:  Diego Cadavid; Yunhong Bai; Donna Dail; Marie Hurd; Kavi Narayan; Emir Hodzic; Stephen W Barthold; Andrew R Pachner
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.